These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Influence of country-level differences on COPD prevalence. Aaron SD; Gershon AS; Gao Y; Yang J; Whitmore GA Int J Chron Obstruct Pulmon Dis; 2016; 11():2305-2313. PubMed ID: 27698561 [TBL] [Abstract][Full Text] [Related]
28. [Meta-analysis of the Italian studies on short-term effects of air pollution]. Biggeri A; Bellini P; Terracini B; Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Lindberg A; Jonsson AC; Rönmark E; Lundgren R; Larsson LG; Lundbäck B Respiration; 2005; 72(5):471-9. PubMed ID: 16210885 [TBL] [Abstract][Full Text] [Related]
30. Epidemiology of chronic obstructive pulmonary disease: a population-based study in Krasnoyarsk region, Russia. Artyukhov IP; Arshukova IL; Dobretsova EA; Dugina TA; Shulmin AV; Demko IV Int J Chron Obstruct Pulmon Dis; 2015; 10():1781-6. PubMed ID: 26366070 [TBL] [Abstract][Full Text] [Related]
31. The prevalence and incidence of COPD among urban older persons of Bangkok Metropolis. Maranetra KN; Chuaychoo B; Dejsomritrutai W; Chierakul N; Nana A; Lertakyamanee J; Naruman C; Suthamsmai T; Sangkaew S; Sreelum W; Aksornin M; Dechapol J; Sathet W J Med Assoc Thai; 2002 Nov; 85(11):1147-55. PubMed ID: 12546310 [TBL] [Abstract][Full Text] [Related]
32. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Wong WL; Su X; Li X; Cheung CM; Klein R; Cheng CY; Wong TY Lancet Glob Health; 2014 Feb; 2(2):e106-16. PubMed ID: 25104651 [TBL] [Abstract][Full Text] [Related]
33. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities. Menezes AM; Victora CG; Perez-Padilla R; BMC Med Res Methodol; 2004 Jun; 4():15. PubMed ID: 15202950 [TBL] [Abstract][Full Text] [Related]
34. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands. Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067 [TBL] [Abstract][Full Text] [Related]
35. Prevalence and predictors of undiagnosed chronic obstructive pulmonary disease in a Norwegian adult general population. Hvidsten SC; Storesund L; Wentzel-Larsen T; Gulsvik A; Lehmann S Clin Respir J; 2010 Jan; 4(1):13-21. PubMed ID: 20298413 [TBL] [Abstract][Full Text] [Related]
36. [Prevalence of chronic obstructive pulmonary disease in Ningxia Hui Autonomous Region of China]. Qiu J; Zhang YN; Chen J; Luo T; Yu XH; Wang JC; Tan H; Lu XL; Zhang J Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):265-8. PubMed ID: 23945339 [TBL] [Abstract][Full Text] [Related]
37. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. van Durme YMTA; Verhamme KMC; Stijnen T; van Rooij FJA; Van Pottelberge GR; Hofman A; Joos GF; Stricker BHC; Brusselle GG Chest; 2009 Feb; 135(2):368-377. PubMed ID: 19201711 [TBL] [Abstract][Full Text] [Related]
38. Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis. Luo J; Wang K; Liu D; Liang BM; Liu CT Respir Res; 2016 Feb; 17():18. PubMed ID: 26887407 [TBL] [Abstract][Full Text] [Related]
40. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea. Kim SJ; Suk MH; Choi HM; Kimm KC; Jung KH; Lee SY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH Int J Tuberc Lung Dis; 2006 Dec; 10(12):1393-8. PubMed ID: 17167958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]